膀胱透明细胞癌:系统评价。
Clear cell carcinoma of the urinary bladder: a systematic review.
机构信息
Department of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
出版信息
Int Urol Nephrol. 2021 May;53(5):815-824. doi: 10.1007/s11255-020-02725-2. Epub 2021 Jan 18.
PURPOSE
We conducted a systematic review of the literature on primary clear cell carcinoma (CCC) of the urinary bladder.
METHODS
A literature search using keywords and MeSH terms related to "clear cell carcinoma", "clear cell adenocarcinoma", "mesonephroma" and "urinary bladder" in EMBASE, MEDLINE and Cochrane Central Register of Controlled Trials was performed. A manual search was performed with web-based search engine Google Scholar. Reference lists of the included studies were screened for additional articles. Articles up till 16th July 2020 were retrieved. Observational human studies on primary CCC in urinary bladder with English full-text were included for further analysis.
RESULTS
904 articles were identified and 44 articles were included for further analysis. Data including clinical features, tumour characteristics, treatment and oncological outcomes were reviewed. There were 70 patients (44 females and 26 males) reported in literatures and included in this review. Gross haematuria was the most common presentation (79.7%), followed by irritative urinary symptoms (47.5%). Regarding the histology, tubulocystic pattern is the most common histologic pattern (49.1%), and 52.6% had muscle invasion. Most cases were CK7 (96.6%) and CK20 (88.9%) positive. CA125 (96%) was commonly positive, indicating its potential origin from mullerian duct. Most patients received surgery (95.5%) as primary treatment. However, the oncological outcomes were unsatisfactory with a 2-year survival rate of 60.0%.
CONCLUSION
Clear cell carcinoma is an uncommon subtype of bladder cancer which can be diagnosed by histology and immunohistochemical staining result. The majority of patients presented with muscle invasion and had a poor survival despite aggressive treatment.
目的
我们对原发性透明细胞膀胱癌的文献进行了系统回顾。
方法
使用 EMBASE、MEDLINE 和 Cochrane 对照试验中心注册数据库中与“透明细胞癌”、“透明细胞腺癌”、“中肾瘤”和“膀胱”相关的关键词和 MeSH 术语进行文献检索,并使用基于网络的搜索引擎 Google Scholar 进行手动检索。检索截至 2020 年 7 月 16 日的文献。纳入研究的参考文献列表中也进行了额外文章的筛选。纳入了 904 篇文章,其中 44 篇文章进一步进行了分析。对包括临床特征、肿瘤特征、治疗和肿瘤学结果在内的数据进行了综述。文献中有 70 例患者(44 名女性和 26 名男性)符合条件并纳入了本次回顾。肉眼血尿是最常见的表现(79.7%),其次是刺激性尿路症状(47.5%)。在组织学方面,管状囊性模式是最常见的组织学模式(49.1%),52.6%的病例有肌肉浸润。大多数病例 CK7(96.6%)和 CK20(88.9%)阳性。CA125(96%)通常呈阳性,表明其可能来源于苗勒管。大多数患者接受手术(95.5%)作为主要治疗方法。然而,肿瘤学结果并不令人满意,2 年生存率为 60.0%。
结论
透明细胞癌是膀胱癌的一种罕见亚型,可通过组织学和免疫组织化学染色结果进行诊断。大多数患者表现为肌肉浸润,尽管采取了积极的治疗,但生存状况较差。